BACKGROUND: Since apoptosis plays a key role in cancer progression, the present study analyzed the polymorphisms of apoptosis-related genes and their impact on survival after curative resection in patients with colorectal cancer. MATERIALS AND METHODS: Three hundred and seventy-seven patients were enrolled in the present study. The genomic DNA was extracted from fresh colorectal mucosal tissue, and 15 SNPs of 12 apoptosis-related genes were determined using a Sequenom MassARRAY system. RESULTS: During the median follow-up of 41.8 (range, 1.1-85.5) months patients alive at last follow-up, 65 relapses and 57 deaths occurred. Among the target polymorphisms, the RIPK1 rs2272990 in a dominant model and the CASP7 rs2227310 in a recessive model of the minor allele were associated with survival in a log-rank test. Moreover, the GA+AA genotype of the RIPK1 rs2272990 and the GG genotype of the CASP7 rs2227310 were significantly correlated with a worse disease-free (hazard ratio [HR] = 2.093; P = 0.007 and HR = 2.641; 0.002, respectively) and disease-specific survival (HR = 2.222; P = 0.013 and HR = 2.247; P = 0.031, respectively) in a multivariate survival analysis. CONCLUSION: The RIPK1 and CASP7 polymorphisms can be considered as possible prognostic markers for survival after curative resection in patients with colorectal cancer.
BACKGROUND: Since apoptosis plays a key role in cancer progression, the present study analyzed the polymorphisms of apoptosis-related genes and their impact on survival after curative resection in patients with colorectal cancer. MATERIALS AND METHODS: Three hundred and seventy-seven patients were enrolled in the present study. The genomic DNA was extracted from fresh colorectal mucosal tissue, and 15 SNPs of 12 apoptosis-related genes were determined using a Sequenom MassARRAY system. RESULTS: During the median follow-up of 41.8 (range, 1.1-85.5) months patients alive at last follow-up, 65 relapses and 57 deaths occurred. Among the target polymorphisms, the RIPK1rs2272990 in a dominant model and the CASP7rs2227310 in a recessive model of the minor allele were associated with survival in a log-rank test. Moreover, the GA+AA genotype of the RIPK1rs2272990 and the GG genotype of the CASP7rs2227310 were significantly correlated with a worse disease-free (hazard ratio [HR] = 2.093; P = 0.007 and HR = 2.641; 0.002, respectively) and disease-specific survival (HR = 2.222; P = 0.013 and HR = 2.247; P = 0.031, respectively) in a multivariate survival analysis. CONCLUSION: The RIPK1 and CASP7 polymorphisms can be considered as possible prognostic markers for survival after curative resection in patients with colorectal cancer.
Authors: L H Colbert; T J Hartman; N Malila; P J Limburg; P Pietinen; J Virtamo; P R Taylor; D Albanes Journal: Cancer Epidemiol Biomarkers Prev Date: 2001-03 Impact factor: 4.254
Authors: Ulrich H Frey; Hakan Alakus; Jeremias Wohlschlaeger; Klaus J Schmitz; Günther Winde; Hans G van Calker; Karl-Heinz Jöckel; Winfried Siffert; Kurt W Schmid Journal: Clin Cancer Res Date: 2005-07-15 Impact factor: 12.531
Authors: Seongmi Park; Dawen Zhao; Kimmo J Hatanpaa; Bruce E Mickey; Debabrata Saha; David A Boothman; Michael D Story; Eric T Wong; Sandeep Burma; Maria-Magdalena Georgescu; Vivek M Rangnekar; Sandili S Chauncey; Amyn A Habib Journal: Cancer Res Date: 2009-05-12 Impact factor: 12.701
Authors: Preetha Rajaraman; Sophia S Wang; Nathaniel Rothman; Merideth M Brown; Peter M Black; Howard A Fine; Jay S Loeffler; Robert G Selker; William R Shapiro; Stephen J Chanock; Peter D Inskip Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-08 Impact factor: 4.254
Authors: Seongmi Park; Kimmo J Hatanpaa; Yang Xie; Bruce E Mickey; Christopher J Madden; Jack M Raisanen; Deepti B Ramnarain; Guanghua Xiao; Debabrata Saha; David A Boothman; Dawen Zhao; Robert M Bachoo; Russell O Pieper; Amyn A Habib Journal: Cancer Res Date: 2009-04-01 Impact factor: 12.701
Authors: Kaye M Reid-Lombardo; Brooke L Fridley; William R Bamlet; Julie M Cunningham; Michael G Sarr; Gloria M Petersen Journal: Ann Surg Date: 2013-06 Impact factor: 12.969
Authors: Jun Young Choi; Jong Gwang Kim; You Jin Lee; Yee Soo Chae; Sang Kyun Sohn; Joon Ho Moon; Byung Woog Kang; Min Kyu Jung; Seong Woo Jeon; Jun Seok Park; Gyu Seog Choi Journal: Cancer Res Treat Date: 2012-03-31 Impact factor: 4.679